Reduced expression of the transporter associated with antigen processing 1 molecule in malignant glioma cells, and its restoration by interferon-γ and -β

Journal of Neurosurgery

Volumn 104, Issue 2, 2006, Pages 264-271

  Satoh, Eiji ^a   Mabuchi, Tadashi ^a   Satoh, Hiroki ^a   Asahara, Takayuki ^a   Nukui, Hideaki ^a   Naganuma, Hirofumi ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Interferon ; Interferon ; Low molecular mass polypeptide 2; Malignant glioma; Transporter associated with antigen processing 1

Indexed keywords

ANTIGEN; BETA INTERFERON; GAMMA INTERFERON; LOW MOLECULAR MASS POLYPEPTIDE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; POLYPEPTIDE; PROTEASOME; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; GENE MUTATION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LYMPHOBLASTOID CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN NEOPLASMS; GLIOMA; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; MAJOR HISTOCOMPATIBILITY COMPLEX; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33644511414     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.104.2.264     Document Type: Article

References (39)

1. Beck S, Kelly A, Radley E, Khurshid F, Alderton RP, Trowsdale J: DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing. J Mol Biol 228:433-441, 1992
2. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, et al: Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179:335-340, 1994
3. Deverson EV, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC: MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348:738-741, 1990
4. Driscoll J, Brown MG, Finley D, Monaco JJ: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262-264, 1993
5. Gaczynska M, Rock KL, Goldberg AL: γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264-267, 1993
6. Glynne R, Powis SH, Beck S, Kelly A, Kerr LA, Trowsdale J: A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357-360, 1991
7. Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, Dranoff G, et al: Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol 103:16-25, 2000
8. Jamaluddin M, Wang S, Garofalo RP, Elliott T, Casola A, Baron S, et al: IFN-β mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 280:L248-L257, 2001
9. Kageshita T, Hirai S, Ono T, Hicklin DJ, Ferrone S: Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol 154:745-754, 1999
10. Kaklamanis L, Townsend A, Doussis-Anagnostopoulou IA, Mortensen N, Harris AL, Gatter KC: Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 145:505-509, 1994
11. Kamarashev J, Ferrone S, Seifert B, Boni R, Nestle FO, Burg G, et al: TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer 95:23-28, 2001
12. Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T: Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50:337-344, 2001
13. Kobayashi T, Yamanaka R, Homma J, Tsuchiya N, Yajima N, Yoshida S, et al: Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma. Cancer Immunol Immunother 52:632-637, 2003
14. Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC: Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 73:148-153, 1996
15. Ma W, Lehner PJ, Cresswell P, Pober JS, Johnson DR: Interferon-γ rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells. J Biol Chem 272:16585-16590, 1997
16. Matsui M, Machida S, Itani-Yohda T, Akatsuka T: Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-γ. J Gastroenterol Hepatol 17:897-907, 2002
17. Min W, Pober JS, Johnson DR: Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-α/β and the IFN-γ signal-transduction pathways. Circ Res 83:815-823, 1998
18. Nagy N, Vanky F, Klein E: Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-α and TNF-γ. Immunol Lett 64:153-160, 1998
19. Neefjes JJ, Momburg F, Hammerling GJ: Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769-771, 1993
20. Ortiz-Navarrete V, Seelig A, Gernold M, Frentzel S, Kloetzel PM, Hammerling GJ: Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353:662-664, 1991
21. Parney IF, Farr-Jones MA, Chang LJ, Petruk KC: Human glioma immunobiology in vitro: implications for immunogene therapy. Neurosurgery 46:1169-1178, 2000
22. Powis SJ, Townsend ARM, Deverson EV, Bastin J, Butcher GW, Howard JC: Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354:528-531, 1991
23. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA, et al: Identification of human cancers deficient in antigen processing. J Exp Med 177:265-272, 1993
24. Seliger B, Atkins D, Bock M, Ritz U, Ferrone S, Huber C, et al: Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Clin Cancer Res 9:1721-1727, 2003
25. Seliger B, Bock M, Ritz U, Huber C: High frequency of a nonfunctional TAP1/LMP2 promoter polymorphism in human tumors. Int J Oncol 20:349-353, 2002
26. Seliger B, Dunn T, Schwenzer A, Casper J, Huber C, Schmoll HJ: Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-γ. Scand J Immunol 46:625-632, 1997
27. Seliger B, Hammers S, Höhne A, Zeidler R, Knuth A, Gerharz C, et al: IFN-γ-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma. Clin Cancer Res 3:573-578, 1997
28. Shi L, Yan G, Fu Y, Ma L, Penfornis A, Faustman D: Human TAP1 polymorphisms detected by denaturing gradient gel electrophoresis. Tissue Antigens 49:421-426, 1997
29. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, Demars R: Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355:644-646, 1992
30. Spies T, Demars R: Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351:323-324, 1991
31. Townsend ARM, Gotch FM, Davey J: Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457-467, 1985
32. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959-968, 1986
33. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 348:741-744, 1990
34. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S: TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-81 T cells. Cell 71:1205-1214, 1992
35. Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Caudei M, et al: HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res 58:737-742, 1998
36. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JPY, et al: Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 181:1459-1471, 1995
37. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, et al: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61:842-847, 2001
38. Yung WK, Castellanos AM, Van Tassel P, Moser RP, Marcus SG: A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma. J Neurooncol 9:29-34, 1990
39. Zhang L, Yamane T, Satoh E, Amagasaki K, Kawataki T, Asahara T, et al: Establishment and patial characterization of five malignant glioma cell lines. Neuropathology 25:136-143, 2005